Mohamed Elbakry

Title: The Innovative Contributions of Mohamed Elbakry

Introduction

Mohamed Elbakry is a notable inventor based in Montréal, Canada. He has made significant strides in the field of medical research, particularly concerning adolescent idiopathic scoliosis (AIS). His work focuses on the stratification of subjects at risk for developing scoliosis, which has important implications for diagnosis and treatment.

Latest Patents

Elbakry holds a patent for a composition that includes a cell sample from a subject with scoliosis and a reagent for detecting PTPμ or PIPK1γ. This patent outlines methods for stratifying subjects with or at risk for developing AIS into clinically useful subclasses. The stratification is based on the expression and activity of PTPμ and PIPK1γ. Additionally, the patent provides methods for predicting the risk of developing scoliosis based on these expressions and activities. It also includes methods for enhancing GiPCR signaling in cells of subjects in need, through the administration of specific inhibitors and activators.

Career Highlights

Elbakry is affiliated with Chu Sainte-Justine, a prominent healthcare institution in Canada. His work there has allowed him to contribute to significant advancements in understanding and treating scoliosis. His innovative approach to research has garnered attention in the medical community.

Collaborations

Elbakry collaborates with esteemed colleagues, including Alain Moreau and Marie-Yvonne Akoume Ndong. Their combined expertise enhances the research efforts at Chu Sainte-Justine, fostering an environment of innovation and discovery.

Conclusion

Mohamed Elbakry's contributions to the field of scoliosis research exemplify the impact of innovative thinking in medicine. His patent and collaborative efforts are paving the way for improved diagnostic and treatment methods for adolescent idiopathic scoliosis.